Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways.
Perspectives on Safety and Efficacy-The BOLD Phase 2 Extension Study of Siponimod in Relapsing-Remitting Multiple Sclerosis.
Organochlorine chemicals and neurodegeneration among elderly subjects in Costa Rica.
Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes.
Intraneural injection of a test dose of local anesthetic in peripheral nerves - does it induce histological changes in nerve tissue?
Autoimmunity in 2015.
Blocking Glutamate Carboxypeptidase II Inhibits Glutamate Excitotoxicity and Regulates Immune Responses in Experimental Autoimmune Encephalomyelitis.
MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.
Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends.
Comparison of myelin water fraction values in periventricular white matter lesions between MS and NMOSD.
Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis.
Retinal measures correlate with cognitive and physical disability in early multiple sclerosis.
Multiple sclerosis: Pregnancy and women's health issues.
Pediatric multiple sclerosis: Conventional first-line treatment and general management.
Acute Transverse Myelitis and Nicolau Syndrome after Benzathine Penicillin Injection.
Assessment of brain metabolite correlates of AAV-mediated overexpression of human alpha-synuclein in cortical neurons by in vivo(1) H-MR spectroscopy at 9.4 T.
Patient Management Problem.
New Approaches to the Diagnosis, Clinical Course, and Goals of Therapy in Multiple Sclerosis and Related Disorders.
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology.
US health insurance is an obstacle to disease-modifying treatments in MS.
Relationships between trunk performance, gait and postural control in persons with multiple sclerosis.
Anconeus Epitrochlearis Muscle Causing Ulnar Neuropathy at the Elbow: Clinical and Neurophysiological Differential Diagnosis.
Methylprednisolone microsphere sustained-release membrane inhibits scar formation at the site of peripheral nerve lesion.
The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China.
Clinical characteristics of disabling attacks at onset in patients with neuromyelitis optica spectrum disorder.
Pages
« first
‹ previous
…
760
761
762
763
764
765
766
767
768
…
next ›
last »